Structure Therapeutics Inc. Gains 54.21%
Mon, Jun 03, 2024 at 07:20 PM
Structure Therapeutics Inc. (GPCR:NASDAQ) shot up at $52.74, representing a gain of 54.2%. On Mon, Jun 03, 2024, GPCR:NASDAQ touched a New 2-Week High of $52.74. The stock appeared on our News Catalysts scanner on Mon, Jun 03, 2024 at 07:01 PM in the 'MISCELLANEOUS' category. From Mon, May 20, 2024, the stock recorded 66.67% Up Days and 20.00% Green Days
About Structure Therapeutics Inc. (GPCR:NASDAQ)
Structure Therapeutics Inc is a clinical stage global biopharmaceutical company aiming to develop and deliver novel oral therapeutics to treat a wide range of chronic diseases with unmet medical need.
Top 10 Gainers:
- Avalon GloboCare Corp. (ALBT:NASDAQ), 316.95%
- Calithera Biosciences, Inc. (CALA:NASDAQ), 100%
- Hywin Holdings Ltd. (HYW:NASDAQ), 91.19%
- Affimed N.V. (AFMD:NASDAQ), 68.51%
- Schmitt Industries, Inc. (SMIT:NASDAQ), 61.29%
- Concord Medical Services Holdings Limited (CCM:NYSE), 57.99%
- Bio-Path Holdings, Inc. (BPTH:NASDAQ), 56.8%
- Structure Therapeutics Inc. (GPCR:NASDAQ), 54.21%
- Histogen Inc. (HSTO:NASDAQ), 45.35%
- Power REIT (PW:NYSEMKT), 39.1%